OBJECTIVE: We performed an evaluation of patient symptoms, health care use, and costs to
define the burden of illness of irritable bowel syndrome (IBS) and the relation to the severity …

BACKGROUND & AIMS: Irritable bowel syndrome (IBS) imposes significant clinical and
economic burdens. We aimed to characterize practice patterns for patients with IBS in a …

Irritable Bowel Syndrome (IBS) is a multisymptom condition defined by abdominal pain,
abdominal discomfort, and abnormalities in stool form and frequency. 1 IBS is a highly …

Irritable bowel syndrome (IBS) is the most prevalent of the functional gastrointestinal
disorders (FGIDs). Current estimates are that IBS affects up to 10–12% of adults in North …

BACKGROUND Comorbid nongastrointestinal symptoms account for two-thirds of excess
health-care costs in irritable bowel syndrome (IBS). OBJECTIVES To determine whether IBS …

OBJECTIVES: The aims of this study were: 1) to determine the total costs of care and costs
related to lower GI–related problems for patients who received a diagnosis of irritable bowel …

Objectives: Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by
symptoms including abdominal pain and altered bowel function. Up to 75% of individuals …

Objective: To examine the economic implications of current irritable bowel syndrome (IBS)
management practices and formulate recommendations based on these implications …

Background Previous studies have demonstrated a substantial economic impact of irritable
bowel syndrome (IBS). Aims To provide contemporaneous estimates of direct healthcare …

Irritable bowel syndrome (IBS) is a chronic disorder with symptoms that range in severity
from mild and intermittent to severe and continuous. Although severity is a guiding factor in …